相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
N. Putzki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Norman Putzki et al.
EUROPEAN NEUROLOGY (2010)
Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice
Olivier Outteryck et al.
JOURNAL OF NEUROLOGY (2010)
Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study
A. B. Oturai et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
N. Putzki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
Michael Hutchinson et al.
JOURNAL OF NEUROLOGY (2009)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
The search for responsive clinical endpoints in primary progressive multiple sclerosis
L. V. A. E. Bosma et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
The pharmacovigilance program on natalizumab in Italy: 2 years of experience
G. Tedeschi et al.
NEUROLOGICAL SCIENCES (2009)
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis
J. J. Kragt et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
分享论文
